# Description of Patients With Type 1 Diabetes Treated With Teplizumab

> **NCT06892002** · — · COMPLETED · sponsor: **Sanofi** · enrollment: 110 (actual)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DRUG:** Teplizumab

## Key facts

- **NCT ID:** NCT06892002
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2025-02-11
- **Primary completion:** 2025-08-05
- **Final completion:** 2025-08-05
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2025-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06892002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06892002, "Description of Patients With Type 1 Diabetes Treated With Teplizumab". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06892002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*